Healthcare Provider's Guide to Ketamine Therapy Referrals

Ketamine Therapy Referrals: A Guide for Healthcare Providers

As ketamine therapy becomes more mainstream for treatment-resistant depression, anxiety, and PTSD, healthcare providers across specialties are encountering patients who ask about or could benefit from this treatment. Understanding when and how to refer patients can improve outcomes for those who haven't found success with traditional approaches.

When to Consider Ketamine Therapy Referrals

Primary Candidates

• Treatment-resistant depression: Patients who haven't responded to 2+ antidepressant trials
• Severe suicidal ideation: When rapid intervention is needed
• PTSD non-responders: Patients who haven't improved with trauma-focused therapy or SSRIs
• Anxiety disorders: Particularly when accompanied by depression or when SSRIs are poorly tolerated
• Bipolar depression: During depressive episodes in patients with bipolar disorder

Clinical Indicators

• Multiple failed antidepressant trials
• Intolerable side effects from traditional medications
• Urgent need for rapid symptom relief
• Patient preference for alternative treatment approaches
• Comorbid conditions that complicate traditional treatment

Understanding Treatment Options

Spravato (Esketamine Nasal Spray)

• FDA approved: Specifically for treatment-resistant depression
• Insurance coverage: More likely to be covered
• Administration: Must be given in certified facilities
• Monitoring: Requires 2+ hours of supervision per session
• Referral process: Direct to certified Spravato providers

At-Home Oral Ketamine

• Off-label prescribing: Legal and increasingly common
• Self-pay: Typically not covered by insurance
• Convenience: Taken at home under telehealth supervision
• Lower doses: Generally fewer side effects than IV treatments
• Referral process: To specialized ketamine therapy providers

IV Ketamine Clinics

• Established treatment: Longest track record for mental health use
• Higher doses: May be more effective for some patients
• Intensive monitoring: Full medical supervision
• Cost: Most expensive option, rarely covered
• Referral process: To specialized ketamine infusion centers

Patient Selection Criteria

Good Candidates

• Stable cardiovascular status
• Controlled blood pressure
• No active psychosis or untreated bipolar mania
• Absence of active substance abuse
• Able to follow treatment protocols
• Realistic expectations about treatment outcomes

Relative Contraindications

• Uncontrolled hypertension
• Recent heart attack or unstable cardiac conditions
• Active psychosis or schizophrenia
• Current substance abuse (particularly stimulants)
• Pregnancy or breastfeeding (requires careful evaluation)
• Severe cognitive impairment

Making Appropriate Referrals

Information to Provide

• Complete medication trial history
• Current diagnoses and symptom severity
• Medical history, particularly cardiovascular
• Current medications and dosages
• Previous therapy history and outcomes
• Substance use history
• Patient's treatment goals and preferences

Referral Letter Template

Include essential information such as:

• Patient demographics and contact information
• Primary psychiatric diagnoses
• Treatment resistance documentation
• Medical comorbidities
• Current medications
• Urgency level and clinical reasoning for referral

Coordinating Care

Ongoing Communication

• Request regular updates from ketamine provider
• Monitor for changes in patient's overall health
• Coordinate medication adjustments
• Provide ongoing primary care or specialty care

Managing Expectations

• Discuss realistic timelines for improvement
• Explain that ketamine isn't effective for everyone
• Address cost and insurance coverage issues
• Prepare patients for the treatment process

Legal and Regulatory Considerations

Off-Label Prescribing

• Ketamine has been FDA-approved since 1970 for anesthesia
• Off-label use for psychiatric conditions is legal and common
• Standard informed consent principles apply
• Documentation requirements same as other treatments

State Variations

• Some states have additional requirements for ketamine prescribing
• Telehealth regulations vary by state
• Provider licensing requirements differ
• Stay informed about local regulations

Common Provider Concerns

"Is ketamine safe?"

At therapeutic doses with proper monitoring, ketamine has an established safety profile. Serious adverse events are rare when prescribed appropriately.

"Will patients become addicted?"

Physical dependence is not a significant concern with prescribed ketamine therapy. The structured, medical setting minimizes abuse potential.

"How do I know if it's working?"

Use standardized rating scales (PHQ-9, GAD-7, PCL-5) to track progress. Many patients show improvement within days to weeks.

"What if traditional treatments haven't been tried?"

Ketamine is typically reserved for treatment-resistant cases, but may be considered earlier in certain circumstances (severe suicidality, intolerable side effects from first-line treatments).

Building Ketamine Knowledge

Educational Resources

• American Psychiatric Association guidelines
• Consensus statements from ketamine professional organizations
• Continuing medical education programs
• Peer-reviewed literature on ketamine therapy

Professional Development

• Attend conferences with ketamine therapy sessions
• Network with providers experienced in ketamine treatment
• Consider ketamine therapy training programs
• Join professional forums and discussion groups

Patient Education Points

When discussing ketamine therapy with patients:

• Explain the difference between medical and recreational use
• Discuss realistic expectations and timelines
• Address cost and insurance considerations
• Provide information about different treatment modalities
• Emphasize the importance of ongoing medical supervision

The Bottom Line

Ketamine therapy represents a valuable option for patients with treatment-resistant mental health conditions. As a referring provider, your role is to identify appropriate candidates, provide comprehensive referral information, and maintain coordinated care throughout the treatment process.

While ketamine isn't appropriate for every patient, it can be life-changing for those who haven't found success with traditional treatments. Understanding when and how to refer patients ensures they have access to all available treatment options. Ready to take the next step? Get started with Kalm today. Explore the Kalm program.